Paris, France, Cambridge, USA, April 2nd, 2025 - TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, is proud to unveil clinical data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback